Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs
Health Canada recommends modified wording for the indications and clinical uses of fludeoxyglucose (F-18 FDG) products in their product monographs. The modified wording aims to bring the indications and clinical uses for F-18 FDG up-to-date and harmonize the product monographs in this regard.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographsHTMLEnglish publication HTML
-
Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographsHTMLFrench publication HTML
Similar records